IRIS - Res&Arch Institutional Research Information System - Research & Archive

MANCUSI, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 742
EU - Europa 551
AS - Asia 235
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 742
IT - Italia 175
IE - Irlanda 148
HK - Hong Kong 87
SG - Singapore 69
CN - Cina 57
UA - Ucraina 57
SE - Svezia 37
DE - Germania 30
FI - Finlandia 29
RU - Federazione Russa 27
KR - Corea 15
CZ - Repubblica Ceca 11
GB - Regno Unito 8
BE - Belgio 7
CH - Svizzera 7
NL - Olanda 5
PL - Polonia 3
AT - Austria 2
AU - Australia 2
FR - Francia 2
GR - Grecia 2
LB - Libano 2
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.531
Salva come PNG Salva come JPEG
Città #
Chandler 162
Dublin 148
Boardman 90
Hong Kong 87
San Mateo 87
Perugia 71
Singapore 46
Altamura 29
Medford 26
Princeton 26
Lawrence 24
Wilmington 24
Jacksonville 23
Andover 22
Beijing 22
Ann Arbor 15
Redmond 15
Seoul 15
Des Moines 12
Munich 11
Norwalk 10
Houston 9
Saint Petersburg 9
Brno 8
West Jordan 8
Helsinki 7
Milan 7
Padova 7
Los Angeles 6
Rome 6
Ancona 5
Brussels 5
Falls Church 5
Florence 5
Marsciano 5
Ashburn 4
Dallas 4
Deruta 4
Foligno 4
New York 4
Redwood City 4
San Paolo di Civitate 4
Santa Clara 4
Shanghai 4
Amsterdam 3
Aurora 3
Nuremberg 3
Terni 3
Vigodarzere 3
Den Haag 2
Lappeenranta 2
Olomouc 2
Santarcangelo di Romagna 2
Venice 2
Woodbridge 2
Zaventem 2
Auburn Hills 1
Bologna 1
Clifton 1
Dearborn 1
Frankfurt am Main 1
Grosseto 1
Izmir 1
Lonate Ceppino 1
Mirano 1
Moscow 1
Riyadh 1
San Diego 1
Taipei 1
Vienna 1
Zagreb 1
Totale 1.137
Salva come PNG Salva come JPEG
Nome #
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 96
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 66
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 66
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 62
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 61
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 60
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 58
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 57
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 52
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 51
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 51
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 49
New mechanism of lymphoma-induced bone marrow aplasia 49
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 47
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 46
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 46
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 45
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 45
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 43
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 40
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 39
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 38
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 37
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 36
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 36
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 35
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 34
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 25
Natural killer cells as a therapeutic tool in mismatched transplantation 24
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 22
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 22
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 21
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 20
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 19
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 17
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 17
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 15
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 15
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 14
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 13
null 11
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation 10
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 10
Totale 1.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 0 0 6 4 5 1 8 0 20 32 10 6
2020/2021149 5 13 3 12 57 9 8 3 12 3 20 4
2021/2022273 1 69 2 6 18 3 4 77 3 20 34 36
2022/2023486 29 102 5 36 32 51 0 19 162 3 31 16
2023/2024381 14 32 7 10 0 11 77 2 24 15 88 101
2024/2025124 34 66 24 0 0 0 0 0 0 0 0 0
Totale 1.620